Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Home
Prescient Therapeutics Ltd
First Patient Dosed on Phase 1b/2 AML Trial
Business
Dec 14 2016
3 min read

First Patient Dosed on Phase 1b/2 AML Trial

news images

Prescient Therapeutics Ltd has released a press release.

View Attachment